IRTC Q4 2022 Earnings — iRhythm Technologies, Inc. Revenue & Financial Results | Market Cap Arena

IRTCiRhythm Technologies, Inc.

$4B

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$113M+37.7% YoY

Gross Profit

$79M69.9% margin

Operating Income

-$21M-18.4% margin

Net Income

-$20M-17.9% margin

EPS (Diluted)

$-0.67

QoQ Revenue Growth

+8.4%

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

$5M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$448M

Total Liabilities

$208M

Stockholders' Equity

$240M

Cash & Equivalents

$79M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$113M	$82M	+37.7%
Gross Profit	$79M	$51M	+53.5%
Operating Income	-$21M	-$32M	+35.7%
Net Income	-$20M	-$32M	+37.8%

Revenue Segments

Commercial Payors

$61M74%

Healthcare Institutions

$14M17%

Non-contracted Third-party Payors

$7M8%